Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 April 2009, doi:10.1136/bmj.b1695
Cite this as: BMJ 2009;338:b1695
John Fletcher, clinical epidemiologist
1 BMJ, London WC1H 9JR
jfletcher{at}bmj.com
The average survival after a diagnosis of multiple sclerosis is much longer than after a diagnosis of cervical cancer. They both have about the same incidence of five per 100 000 per year, although this varies with geography and demography. In a large population the prevalence of multiple sclerosis would then be expected to be:
c—Incidence is measured in units of number of cases in a population in a time period. Prevalence has no units and is simply a proportion—the number of existing cases in a population at a given time. Because prevalence and incidence are different and measured with different units it makes little sense to compare their numerical values as in d and e.
In a stable population with stable disease characteristics prevalence is equal to disease incidence multiplied by average duration of disease. Because people live much longer on average after a diagnosis of multiple sclerosis than after a diagnosis of cervical cancer, the prevalence of multiple sclerosis is much greater than that of cervical cancer.
Cite this as: BMJ 2009;338:b1695